Pharmaceutical & Biotech
News and Insights
Dendreon Files for Bankruptcy
Despite numerous cost cutting measures, Dendreon has filed for Chapter 11 bankruptcy protection. It wasn't too long ago that things looked promising for the company ...
Employee Numbers at Top 10 Pharma Companies
With so many patents expiring in 2012, it was not unexpected that the ten largest big pharma companies would have fewer employees by the end ...
Shire’s CFO is Heading to Severn Trent
Days after the news that AbbVie deal with Shire would not be moving forward, news has come that Shire's interim CFO, James Bowling, will be ...
AstraZeneca Photo-sharing Campaign to Help Fight Breast Cancer
October is Breast cancer awareness month. Yearly recognition of the deadly disease began in 1985 when drug manufacturer AstraZeneca encouraged women to have yearly mammograms. ...
Roche's Perjeta is helping Breast Cancer Patients Live Longer
According to newly released results at the European Society for Medical Oncology, Roche's Perjeta's is lengthening the life expectancy of patients with HER2-positive breast cancer ...
2015 Will Bring Changes for J&J Pension Benefits
In an effort to cut costs, J&J has announced that starting January 1, 2015 the company will reduce the pension benefits it offers to newly ...
Release of generic form of Nexium is delayed
With sales of AstraZeneca's Nexium bringing in over $2 billion in US sales last year, there are several generics makers who are ready to enter ...
Questions about Biosimilars
Recent inquires to the FDA have raised more questions about whether biosimilars should keep the same name as the branded biotech drugs. Doctor's state if ...
Plans for a Future Biotech Hub in New York
Pfizer, Eli Lilly and J&J have each contributed to a $51 million fund which will lay the groundwork the creation of a biotech hub on ...
High Price for Gilead’s Hepatitis C Treatment
Gilead's new hepatitis C treatment Savaldi came on the market in December. At that time, patients were receiving approval for the $84,000 treatment. Fast forward ...
- page 1 of 3 -